Previous studies showed that RIPK2 plays a role in tumor progression; however, these observations were limited to carcinomas of the breast (Zare et al., 2018), bladder (Zhang and Chin, 2014) and colon (Chen et al., 2020). This evidence concerns the gene RIPK2 and neoplasm.